ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,354Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2061

$1.57M Total Retail Price of All Prescriptions

Rank: 28 out of 2061

557 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 16,852 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 1,023 594 1 2
METOPROLOL TARTRATE 826 587 2 7
SIMVASTATIN 783 467 3 1
FUROSEMIDE 726 478 4 6
OMEPRAZOLE 630 449 5 5
TRAMADOL HCL 610 292 6 18
AMLODIPINE BESYLATE 578 413 7 4
CITALOPRAM HBR 536 405 8 20
METFORMIN HCL 522 327 9 9
WARFARIN SODIUM 455 349 10 11
GABAPENTIN 446 260 11 15
LEVOTHYROXINE SODIUM 446 339 11 3
OXYCODONE-ACETAMINOPHEN 416 187 S2 13 36
NABUMETONE 340 148 14 196
NEXIUM 329 169 15 26
DONEPEZIL HCL 329 301 15 24
RISPERIDONE 329 237 15 66
ATENOLOL 328 224 18 13
TAMSULOSIN HCL 310 199 19 30
ZOLPIDEM TARTRATE 284 144 20 23
CARVEDILOL 280 201 21 22
MIRTAZAPINE 267 237 22 46
HYDROCHLOROTHIAZIDE 257 151 23 12
JANTOVEN 251 171 24 93
ATORVASTATIN CALCIUM 249 164 25 8
HYDROCODONE-ACETAMINOPHEN 242 171 S3 26 10
GLIMEPIRIDE 237 137 27 33
NAMENDA 229 219 28 37
ALENDRONATE SODIUM 198 158 29 25
TRAZODONE HCL 192 111 30 39
PROAIR HFA 187 73 31 40
PANTOPRAZOLE SODIUM 182 137 32 45
SERTRALINE HCL 175 96 33 21
CRESTOR 175 88 33 31
CYMBALTA 171 110 35 59
POTASSIUM CHLORIDE 168 121 36 16
JANUVIA 166 110 37 51
DIGOXIN 164 116 38 56
DIVALPROEX SODIUM 160 117 39 74
FAMOTIDINE 155 99 40 67
HYDRALAZINE HCL 153 107 41 69
OLANZAPINE 149 99 42 132
ALLOPURINOL 149 97 42 28
ACTOS 149 102 42 140
SPIRIVA 146 71 45 63
CLOPIDOGREL 144 90 46 29
CLONIDINE HCL 141 66 47 52
METHOCARBAMOL 140 40 R 48 203
LYRICA 139 55 49 83
ISOSORBIDE MONONITRATE ER 135 85 50 42
PAROXETINE HCL 134 94 51 61
QUETIAPINE FUMARATE 131 113 52 72
LANTUS 130 75 53 48
BENZTROPINE MESYLATE 127 80 R 54 149
ADVAIR DISKUS 125 53 55 57
KLOR-CON M20 120 88 56 47
AVODART 119 82 57 356
LOSARTAN POTASSIUM 119 95 57 17
RANITIDINE HCL 117 86 59 53
LEVETIRACETAM 112 48 60 102
EXELON 112 102 60 94
PLAVIX 109 76 62 49
TRICOR 105 66 63 128
LIDODERM 101 83 64 106
FLUTICASONE PROPIONATE 99 55 65 43
CIPROFLOXACIN HCL 99 81 65 54
SPIRONOLACTONE 98 68 67 62
HALOPERIDOL 96 58 68 153
ESCITALOPRAM OXALATE 94 72 69 77
IBUPROFEN 93 34 70 90
CELEBREX 92 62 71 91
METOPROLOL SUCCINATE 91 35 72 19
GLYBURIDE 91 66 R 72 60
MECLIZINE HCL 90 64 74 142
POLYETHYLENE GLYCOL 3350 90 35 74 64
FINASTERIDE 89 62 76 86
ZETIA 89 66 76 68
COMBIVENT 88 40 78 159
SINGULAIR 85 66 79 88
IPRATROPIUM-ALBUTEROL 85 71 79 117
PREDNISONE 85 66 79 32
BACLOFEN 84 18 82 123
NAPROXEN 82 43 83 110
HUMULIN R 82 46 83 301
AZITHROMYCIN 81 50 85 34
AMOX TR-POTASSIUM CLAVULANATE 80 63 86 113
VESICARE 79 0 87 269
PRAVASTATIN SODIUM 79 78 87 14
MELOXICAM 75 45 89 44
OXYCODONE HCL 71 27 S2 90 82
NYSTOP 70 34 91 185
OXYBUTYNIN CHLORIDE ER 70 66 91 80
NASONEX 68 36 93 332
METOCLOPRAMIDE HCL 68 29 93 138
MORPHINE SULFATE ER 68 39 S2 93 166
DOXAZOSIN MESYLATE 68 59 93 81
FENTANYL 67 42 S2 97 84
AMMONIUM LACTATE 67 43 97 338
ABILIFY 66 29 99 160
PHENYTOIN SODIUM EXTENDED 66 35 99 145
LEXAPRO 65 55 101 211
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 38 102 87
LORAZEPAM 62 62 102 96
SYMBICORT 61 43 104 158
NOVOLIN R 60 35 105 129
BUPROPION XL 60 0 105 210
KETOCONAZOLE 60 50 105 230
TRAVATAN Z 59 38 108 245
DICYCLOMINE HCL 57 35 109 207
ONGLYZA 56 31 110 204
CYCLOBENZAPRINE HCL 56 23 R 110 78
DETROL LA 54 38 112 264
CLOZAPINE 54 21 112 164
LEVOFLOXACIN 53 32 114 111
METHYLPREDNISOLONE 52 32 115 101
NITROGLYCERIN PATCH 52 51 115 205
OXYBUTYNIN CHLORIDE 52 28 115 121
FENOFIBRATE 51 16 118 65
PROPRANOLOL HCL 51 38 118 143
DIOVAN 51 39 118 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.